XML 107 R89.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Segment Reporting Information        
Net sales   $ 800,354 $ 827,995 $ 819,982
Depreciation and amortization   32,341 27,564 26,943
Adjusted EBITDA - Total segments   142,318 156,489 162,378
Reconciliation of income before income taxes to Adjusted EBITDA        
Income before income taxes   55,512 71,505 88,070
Interest expense, net   12,856 11,776 11,910
Depreciation and amortization   32,341 27,564 26,943
Stock-based compensation   2,259 2,259 334
Foreign currency (gains) losses, net   826 (55) (1,054)
Adjusted EBITDA - Total segments   142,318 156,489 162,378
Identifiable assets $ 726,671 784,100 726,671  
Animal Health        
Segment Reporting Information        
Net sales   526,904 531,974 531,727
Reconciliation of income before income taxes to Adjusted EBITDA        
Restructure costs 6,281 425    
Mineral Nutrition        
Segment Reporting Information        
Net sales   214,412 233,782 234,922
Performance Products        
Segment Reporting Information        
Net sales   59,038 62,239 53,333
Operating Segments        
Segment Reporting Information        
Net sales   800,354 827,995 819,982
Depreciation and amortization   30,669 25,758 24,847
Adjusted EBITDA - Total segments   142,318 156,489 162,378
Reconciliation of income before income taxes to Adjusted EBITDA        
Income before income taxes   55,512 71,505 88,070
Interest expense, net   12,856 11,776 11,910
Depreciation and amortization   30,669 25,758 24,847
Restructure costs   425 6,281 0
Stock-based compensation   2,259 2,259 334
Acquisition-related costs of goods sold   280 0 1,671
Acquisition-related accrued compensation   0 0 1,152
Acquisition-related transaction costs   462 213 400
Acquisition-related other   (2,821) 0 (468)
Other, net   0 (1,506) 0
Foreign currency (gains) losses, net   826 (55) (1,054)
Adjusted EBITDA - Total segments   142,318 156,489 162,378
Identifiable assets 609,412 657,365 609,412  
Operating Segments | Animal Health        
Segment Reporting Information        
Net sales   526,904 531,974 531,727
Depreciation and amortization   26,287 22,312 21,447
Adjusted EBITDA - Total segments   123,106 136,049 141,914
Reconciliation of income before income taxes to Adjusted EBITDA        
Depreciation and amortization   26,287 22,312 21,447
Adjusted EBITDA - Total segments   123,106 136,049 141,914
Identifiable assets 508,864 560,663 508,864  
Operating Segments | Mineral Nutrition        
Segment Reporting Information        
Net sales   214,412 233,782 234,922
Depreciation and amortization   2,522 2,319 2,371
Adjusted EBITDA - Total segments   14,678 15,712 18,583
Reconciliation of income before income taxes to Adjusted EBITDA        
Depreciation and amortization   2,522 2,319 2,371
Adjusted EBITDA - Total segments   14,678 15,712 18,583
Identifiable assets 67,662 65,686 67,662  
Operating Segments | Performance Products        
Segment Reporting Information        
Net sales   59,038 62,239 53,333
Depreciation and amortization   1,860 1,127 1,029
Adjusted EBITDA - Total segments   4,534 4,728 1,881
Reconciliation of income before income taxes to Adjusted EBITDA        
Depreciation and amortization   1,860 1,127 1,029
Adjusted EBITDA - Total segments   4,534 4,728 1,881
Identifiable assets 32,886 31,016 32,886  
Corporate        
Segment Reporting Information        
Depreciation and amortization   1,672 1,806 2,096
Reconciliation of income before income taxes to Adjusted EBITDA        
Depreciation and amortization   1,672 1,806 2,096
Corporate costs   40,178 38,452 $ 33,420
Identifiable assets $ 117,259 $ 126,735 $ 117,259